Create account

Coverage dated October 26, 2026 to October 27, 2026

Judge denied Novo Nordisk bid to block Eli Lilly weight-loss drug ads

Headline from Quartz

Judge Zahid Quraishi said Novo Nordisk failed to show irreparable harm; the drugmaker says its false advertising suit continues

Quartz's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

3 articles, oldest first.

  1. Bloomberg

    Novo Nordisk Loses Court Ruling Over Eli Lilly Obesity Drug Ads (opens Bloomberg)

    Published

    Bloomberg's feed description

    Novo Nordisk A/S lost a bid in a US court to temporarily block Eli Lilly & Co. from using advertisements that claim its drugs are more powerful, a setback to Novo as it battles to regain a larger share of the obesity and diabetes drug markets.

  2. Quartz

    Judge denied Novo Nordisk bid to block Eli Lilly weight-loss drug ads (opens Quartz)

    Published

    Quartz's feed description

    Judge Zahid Quraishi said Novo Nordisk failed to show irreparable harm; the drugmaker says its false advertising suit continues

  3. STAT

    STAT+: Pharmalittle: We’re reading about a Novo setback in court, a House probe into big PBMs, and more (opens STAT)

    Published

    STAT's feed description

    A U.S. judge rejected a bid to block ‌Eli Lilly from running what Novo Nordisk claims is a “deceptive” advertising campaign about weight loss drugs